Form 8-K - Current report:
SEC Accession No. 0001193125-25-127604
Filing Date
2025-05-27
Accepted
2025-05-27 16:31:27
Documents
13
Period of Report
2025-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d908117d8k.htm   iXBRL 8-K 47202
2 EX-10.1 d908117dex101.htm EX-10.1 120555
  Complete submission text file 0001193125-25-127604.txt   314014

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qdel-20250520.xsd EX-101.SCH 2862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qdel-20250520_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qdel-20250520_pre.xml EX-101.PRE 10820
16 EXTRACTED XBRL INSTANCE DOCUMENT d908117d8k_htm.xml XML 3525
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-41409 | Film No.: 25989064
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)